Number Of Families That Have Filed A Zofran Lawsuit Grows To More Than 230

ZofranLegal.com has announced that more than 230 families have joined the Zofran litigation by filing a lawsuit against the drug manufacturing company, GlaxoSmithKline (GSK).

In each of the complaints, parents are alleging that a child developed a birth defect after the mother was given Zofran as a treatment for morning sickness. Zofran, an anti-nausea medication, was approved for the U.S. market in 1991 by the FDA, however, the administration only indicated that the drug was safe for patients who had undergone treatments involving anesthesia, radiation, and chemotherapy. Since no human clinical trials had been performed on pregnant women, the drug was not approved as a treatment for morning sickness.

Ignoring this fact, GSK advertised the drug as a “safe” and “effective” treatment for pregnant women to both the medical community and the public. Millions of women were prescribed the drug for “off-label” use.

Plaintiffs are claiming that after GSK moved forward with their marketing campaign, the company soon began to receive reports indicating that women who had taken the drug gave birth to children with birth defects, but the company chose to not disclose this information. Birth defects noted in the complaints include clubfoot, cleft lip, cleft palate, atrial septal defect, ventricular septal defect, transposition of the greater vessels, ear deformities, kidney defects, and respiratory distress syndrome. Surgical treatments are needed for the majority of these children and parents have suffered both financially and emotionally due to the trauma their child has been put through so early in life.

By pursuing legal action these plaintiffs are seeking to recover compensation for their child’s medical expenses, any wages lost by parents, the physical pain and suffering of the child, and the emotional trauma experienced by the family.

New lawsuits are being filed regularly and the attorneys at Monheit Law are offering free consultations to those who believe their child’s birth defect may have been caused by Zofran. To learn more, contact Michael Monheit at 877-620-8411.